These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21774618)

  • 1. The formalism of fractal aggregation phenomena of colloidal drug delivery systems.
    Pippa N; Demetzos C; Danezis E
    J Liposome Res; 2012 Mar; 22(1):55-61. PubMed ID: 21774618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental and theoretical studies of the colloidal stability of nanoparticles-a general interpretation based on stability maps.
    Segets D; Marczak R; Schäfer S; Paula C; Gnichwitz JF; Hirsch A; Peukert W
    ACS Nano; 2011 Jun; 5(6):4658-69. PubMed ID: 21545143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fractal hologram and elucidation of the structure of liposomal carriers in aqueous and biological media.
    Pippa N; Pispas S; Demetzos C
    Int J Pharm; 2012 Jul; 430(1-2):65-73. PubMed ID: 22486958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid induced fractal aggregation of gold nanoparticles: Why and how.
    Doyen M; Goole J; Bartik K; Bruylants G
    J Colloid Interface Sci; 2016 Feb; 464():160-6. PubMed ID: 26613335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying colloidal aggregation using liposomes.
    Sabín J; Prieto G; Sarmiento F
    Methods Mol Biol; 2010; 606():189-98. PubMed ID: 20013398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of electrolyte and poloxamer 188 on the aggregation kinetics of solid lipid nanoparticles (SLNs).
    Wei CC; Ge ZQ
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1084-9. PubMed ID: 22181005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the effect of Ca2+ and La3+ on the colloidal stability of liposomes.
    Sabín J; Prieto G; Messina PV; Ruso JM; Hidalgo-Alvarez R; Sarmiento F
    Langmuir; 2005 Nov; 21(24):10968-75. PubMed ID: 16285760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmaceutical applications of the zeta potential--use in characterization of colloidal drug carriers].
    Le Roy Boehm AL; Fessi H
    J Pharm Belg; 2000; 55(2):40-8. PubMed ID: 10842925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyion-induced aggregation of oppositely charged liposomes and charged colloidal particles: the many facets of complex formation in low-density colloidal systems.
    Cametti C
    Chem Phys Lipids; 2008 Oct; 155(2):63-73. PubMed ID: 18718458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of submicron systems via optical methods.
    Haskell RJ
    J Pharm Sci; 1998 Feb; 87(2):125-9. PubMed ID: 9519143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle aggregation: principles and modeling.
    Zhang W
    Adv Exp Med Biol; 2014; 811():19-43. PubMed ID: 24683025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I.
    Abdel-Mottaleb MM; Lamprecht A
    Drug Dev Ind Pharm; 2011 Feb; 37(2):178-84. PubMed ID: 21073322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach to determine the critical coagulation concentration of a colloidal dispersion with plate-like particles.
    Liu L; Moreno L; Neretnieks I
    Langmuir; 2009 Jan; 25(2):688-97. PubMed ID: 19105787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of self-organized multilayer nanoparticles for drug delivery.
    Gerelli Y; Barbieri S; Di Bari MT; Deriu A; Cantù L; Brocca P; Sonvico F; Colombo P; May R; Motta S
    Langmuir; 2008 Oct; 24(20):11378-84. PubMed ID: 18816016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fractal analysis as a complementary approach to predict the stability of drug delivery nano systems (DDnSs) in aqueous and biological media: a regulatory proposal or a dream?
    Demetzos C; Pippa N
    Adv Exp Med Biol; 2015; 822():211-2. PubMed ID: 25416995
    [No Abstract]   [Full Text] [Related]  

  • 16. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
    Gaumet M; Vargas A; Gurny R; Delie F
    Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review on novel vesicular drug delivery: proniosomes.
    Yasam VR; Jakki SL; Natarajan J; Kuppusamy G
    Drug Deliv; 2014 Jun; 21(4):243-9. PubMed ID: 24128089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriate salt concentration of nanodiamond colloids for electrostatic self-assembly seeding of monosized individual diamond nanoparticles on silicon dioxide surfaces.
    Yoshikawa T; Zuerbig V; Gao F; Hoffmann R; Nebel CE; Ambacher O; Lebedev V
    Langmuir; 2015 May; 31(19):5319-25. PubMed ID: 25936368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles.
    Martins S; Sarmento B; Ferreira DC; Souto EB
    Int J Nanomedicine; 2007; 2(4):595-607. PubMed ID: 18203427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.